KJIM :: Korean Journal of Internal Medicine

Letter to the editor regarding “Comparing long-term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial chemoembolization: A propensity score matched study”

European Journal of Radiology.2024; 170: 111211. CrossRef

Frontline evaluation: Atezolizumab–bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up‐to‐seven criteria

Masamichi Kimura, Koji Nishikawa, Jun Imamura, Kiminori Kimura

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects

Hongye Wang, Zhaorong Wu, Dan Cui, Yaoping Shi, Bo Zhai

Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study

European Journal of Radiology.2023; 167: 111092. CrossRef

Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study

Fei Cao, Changsheng Shi, Guofu Zhang, Jun Luo, Jiaping Zheng, Weiyuan Hao

Combination Therapy of Bland Transarterial Embolization and Microwave Ablation for Hepatocellular Carcinoma within the Milan Criteria Leads to Significantly Higher Overall Survival

Response to Letter to the Editor regarding “Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study”

European Journal of Radiology.2023; 169: 111193. CrossRef

Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression

Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang

International Journal of Hyperthermia.2022; 39(1): 1. CrossRef

Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis

Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis

Kota Takaki, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Yuki Zaizen, Takashi Niizeki, Kotaro Kuwaki, Masaru Fukahori, Takahiko Sakaue, Sohei Yoshimura, Mika Nakazaki, Takuji Torimura

Journal of Clinical Medicine.2022; 11(6): 1483. CrossRef

Medical Treatment for Hepatocellular Carcinoma in Japan

Youichi Kawano, Yohei Kaneya, Yuto Aoki, Masato Yoshioka, Akira Matsushita, Tetsuya Shimizu, Junji Ueda, Hideyuki Takata, Nobuhiko Taniai, Tomohiro Kanda, Atsushi Hirakata, Hideyuki Suzuki, Hiroshi Yoshida

Journal of Nippon Medical School.2022; 89(2): 154. CrossRef

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma

Fu-Lei Gao, Yong Wang, Xiang-Zhong Huang, Tian-Fan Pan, Jin-He Guo

Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence–Based Decision-Making Tool

Allen Mo, Christian Velten, Julie M. Jiang, Justin Tang, Nitin Ohri, Shalom Kalnicki, Parsa Mirhaji, Kei Nemoto, Boudewijn Aasman, Madhur Garg, Chandan Guha, N. Patrik Brodin, Rafi Kabarriti

JCO Clinical Cancer Informatics.2022;[Epub] CrossRef

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival

Yu Sun, Honghai Zhang, Jiang Long, Yonghong Zhang, Jiasheng Zheng, Chunwang Yuan

Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea

Sunmin Park, Chai Hong Rim, Young Kul Jung, Won Sup Yoon, Alessandro Granito

Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1. CrossRef

Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis

Chuang Jiang, Gong Cheng, Mingheng Liao, Jiwei Huang

World Journal of Surgical Oncology.2021;[Epub] CrossRef

Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?

Zhaonan Li, Chaoyan Wang, Guangyan Si, Xueliang Zhou, Yahua Li, Jing Li, Dechao Jiao, Xinwei Han

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study

Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis

Zheng Li, Qiang Li, Xiaohu Wang, Weiqiang Chen, Xiaodong Jin, Xinguo Liu, Fei Ye, Zhongying Dai, Xiaogang Zheng, Ping Li, Chao Sun, Xiongxiong Liu, Qiuning Zhang, Hongtao Luo, Ruifeng Liu

The clinical effects of ultrasound-guided microwave ablation in the treatment of primary hepatic carcinoma

Bing Ran, Yong-Li Chang, Jing Qi, Wei Zhong, Min-Na Chen, Wang Zhang, Lin-Xia Meng

Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?

Zeno Sparchez, Pompilia Radu, Adrian Bartos, Iuliana Nenu, Rares Craciun, Tudor Mocan, Adelina Horhat, Mihaela Spârchez, Jean-François Dufour

World Journal of Gastrointestinal Oncology.2021; 13(12): 1896. CrossRef

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma

Feng Duan, Yan-Hua Bai, Li Cui, Xiao-Hui Li, Jie-Yu Yan, Mao-Qiang Wang

World Journal of Gastrointestinal Oncology.2020; 12(1): 92. CrossRef

Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases

Zuo-Hong Ma, Yong-Peng Wang, Wen-Heng Zheng, Ji Ma, Xue Bai, Yong Zhang, Yuan-He Wang, Da Chi, Xi-Bo Fu, Xiang-Dong Hua

World Journal of Gastrointestinal Oncology.2020; 12(10): 1177. CrossRef

Efficacy and Safety of the Radiotherapy for Liver Cancer: Assessment of Local Controllability and Its Role in Multidisciplinary Therapy

Marina Ohkoshi-Yamada, Kenya Kamimura, Osamu Shibata, Shinichi Morita, Motoki Kaidu, Toshimichi Nakano, Katsuya Maruyama, Atsushi Ota, Hirotake Saito, Nobuko Yamana, Tomoya Oshikane, Yukiyo Goto, Natsumi Yoshimura, Satoshi Tanabe, Hisashi Nakano, Madoka S

Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma

Keara English, N. Patrik Brodin, Viswanathan Shankar, Shaoyu Zhu, Nitin Ohri, Yosef S. Golowa, Jacob Cynamon, Sarah Bellemare, Andreas Kaubisch, Milan Kinkhabwala, Shalom Kalnicki, Madhur K. Garg, Chandan Guha, Rafi Kabarriti

JAMA Network Open.2020; 3(11): e2023942. CrossRef

Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment

Ah Ran Kim, Eugene Park, So Young Kwon, Seong Jun Park, Young Jung Kim, Byung Chul Yoo, Won Hyeok Choe, Jeong Han Kim, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi hye Yu, Hae jeong Jeon

The Korean Journal of Gastroenterology.2019; 73(3): 167. CrossRef

Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome

Dan Liu, Ming Liu, Liya Su, Yu Wang, Xiaoer Zhang, Haiyi Long, Ming Kuang, Xiaoyan Xie, Manxia Lin

Journal of Vascular and Interventional Radiology.2019; 30(12): 1879. CrossRef

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective ca

Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm

Yashwant Patidar, Lalit Garg, Amar Mukund, Shiv Kumar Sarin

Indian Journal of Radiology and Imaging.2019; 29(01): 47. CrossRef

Correlations of pri-Let-7 gene polymorphisms with the recurrence and metastasis of primary liver cancer after transcatheter arterial chemoembolization

Pathology - Research and Practice.2018; 214(5): 667. CrossRef

Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A)

Hyukjoon Lee, Chang Jin Yoon, Nak Jong Seong, Sook-Hyang Jeong, Jin-Wook Kim

Korean Journal of Radiology.2018; 19(6): 1130. CrossRef

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana Alcantara Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei-Jer Chen, Cosmas Ri

Hepatology International.2017; 11(4): 317. CrossRef

Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization–Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center

Qi-Feng Chen, Zhen-Yu Jia, Zheng-Qiang Yang, Wen-Long Fan, Hai-Bin Shi

CardioVascular and Interventional Radiology.2017; 40(11): 1748. CrossRef

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma

De-jun Yang, Kun-lun Luo, Hong Liu, Bing Cai, Guo-qing Tao, Xiao-fang Su, Xiao-juan Hou, Fei Ye, Xiang-yong Li, Zhi-qiang Tian